The ASX200 closed down 0.38% at 7,969 points.
Energy was the best performing sector, up1%, followed by Staples, up 0.4%, and Materials, up 0.33%.
Real Estate was the biggest loser, down 2.2%, followed, IT, down 2%, and Discretionary, down 1%.
In the Green
Core Lithium (ASX:CXO) closed up 5.2% following the release of an update on its Finniss Lithium Operation.
Core Lithium closed at 8 cents.
Neuren Pharmaceuticals (ASX:NEU) finished up 0.67% on news the company is developing a new product to treat infant injuries when a baby’s brain does not receive enough oxygen or blood flow before or shortly after birth.
Neuren Pharmaceuticals finished at $12.01.
And, Reject Shop (ASX:TRS) has closed up 109% after investors flocked to the stock as the company received a takeover offer. Canada’s Dollarama (TSX:DOL) cut a deal to buy Reject Shop for $259 million.
Reject Shop closed at $6.60.
In the Red
Domain (ASX:DHG) closed down 4.9% after CoStar Group (NASDAQ:CSGP) improved its takeover offer, from $4.20 cash per share to $4.43 per share.
Domain wrapped up at $4.25.
Pro Medicus (ASX:PME) closed down 7.8% after being swept up in today’s tech sell-off. Broker Macquarie retained its “neutral” rating and its $257.40 price target.
Pro Medicus pulled up stumps at $210.00.
And, WiseTech (ASX:WTC) closed down 2% as investors reacted to Australian Super selling its entire $580M stake in the company. AusSuper’s move came due to “governance concerns” and worries about the board.
Wisetech finished the day at $83.66.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.